MicroRNA-21 Regulates the Proliferation, Differentiation, and Apoptosis of Human Renal Cell Carcinoma Cells by the MTOR-STAT3 Signaling Pathway

Overview

Journal Oncol Res

Specialty Oncology

Date 2016 Oct 8

PMID 27712594

Citations 17

Authors

Tao Liang

Xiao-Yong Hu

Yong-Hui Li

Bin-Qiang Tian

Zuo-Wei Li

Qiang Fu

Affiliations

Soon will be listed here.

Abstract

MicroRNA-21 (miRNA-21), a kind of short, noncoding RNAs, functioned as a tumor marker and was upregulated in renal cell carcinoma (RCC). However, the underlying mechanisms of miRNA-21 in RCC were uncertain. Therefore, the effects and mechanisms of miRNA-21 on the proliferation, differentiation, and apoptosis of cultured human RCC cells were further investigated in this study. After slicing miRNA-21 in RCC cells, the viability, mRNA expression of C/EBPα and PPARγ, caspase 3 activity, and protein expression of mTOR, STAT3, and pSTAT3 were determined. It was found that knockdown of miRNA-21 downregulated the optical density (OD) value of cells, inhibited mRNA expression of PPARγ and C/EBPα, and enhanced activity of caspase 3. Furthermore, protein expression of pSTAT3 was also decreased in the absence of miRNA-21. Notably, miRNA-21-changed proliferation, differentiation, and apoptosis of human RCC cells were partially regulated following the block of the mTOR-STAT3 signaling pathway by the mTOR inhibitor (XL388). It was indicated that miRNA-21 promoted proliferation and differentiation and decreased apoptosis of human RCC cells through the activation of the mTOR-STAT3 signaling pathway.

Citing Articles

MicroRNAs in Genitourinary Malignancies: An Exciting Frontier of Cancer Diagnostics and Therapeutics.

Kathuria-Prakash N, Dave P, Garcia L, Brown P, Drakaki A Int J Mol Sci. 2024; 25(17).

PMID: 39273446 PMC: 11394927. DOI: 10.3390/ijms25179499.

MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications.

Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J Front Cell Dev Biol. 2024; 12:1437951.

PMID: 39114567 PMC: 11304453. DOI: 10.3389/fcell.2024.1437951.

BMP9 induces osteogenic differentiation through up-regulating LGR4 via the mTORC1/Stat3 pathway in mesenchymal stem cells.

Zhang J, Jiang J, Liu H, Wang S, Ke K, Liu S Genes Dis. 2024; 11(3):101075.

PMID: 38292169 PMC: 10825279. DOI: 10.1016/j.gendis.2023.101075.

Modulation of AKT Pathway-Targeting miRNAs for Cancer Cell Treatment with Natural Products.

Shiau J, Chuang Y, Yen C, Chang F, Yang K, Hou M Int J Mol Sci. 2023; 24(4).

PMID: 36835100 PMC: 9961959. DOI: 10.3390/ijms24043688.

LINC00671 inhibits renal cell cancer progression via regulating miR-221-5p/SOCS1 axis.

Jin G, Mi H, Ye Y, Yao Q, Yuan L, Wu X Am J Transl Res. 2021; 13(7):7524-7537.

PMID: 34377233 PMC: 8340225.

References

Huyck L, Ampe C, Van Troys M . The XTT cell proliferation assay applied to cell layers embedded in three-dimensional matrix. Assay Drug Dev Technol. 2012; 10(4):382-92. PMC: 3419859. DOI: 10.1089/adt.2011.391. View

Yang C, Yue J, Fan M, Pfeffer L . IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis. Cancer Res. 2010; 70(20):8108-16. PMC: 3014825. DOI: 10.1158/0008-5472.CAN-10-2579. View

Li X, Xin S, He Z, Che X, Wang J, Xiao X . MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma. Cell Physiol Biochem. 2014; 33(6):1631-42. DOI: 10.1159/000362946. View

Esquela-Kerscher A, Slack F . Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4):259-69. DOI: 10.1038/nrc1840. View

Alemar B, Izetti P, Gregorio C, Macedo G, Castro M, Bersch Osvaldt A . miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. Pancreas. 2015; 45(1):84-92. DOI: 10.1097/MPA.0000000000000383. View

Sun Q, Hang M, Guo X, Shao W, Zeng G . Expression and significance of miRNA-21 and BTG2 in lung cancer. Tumour Biol. 2013; 34(6):4017-26. DOI: 10.1007/s13277-013-0992-8. View

Jin B, Liu Y, Wang H . Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel. Cell Biochem Biophys. 2016; 72(1):275-82. DOI: 10.1007/s12013-014-0450-2. View

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

Kumarswamy R, Volkmann I, Thum T . Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011; 8(5):706-13. PMC: 3256347. DOI: 10.4161/rna.8.5.16154. View

10.

Wu Z, Tao Z, Zhang J, Li T, Ni C, Xie J . MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer. Tumour Biol. 2015; 37(6):7245-54. DOI: 10.1007/s13277-015-4604-7. View

11.

Chan J, Krichevsky A, Kosik K . MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65(14):6029-33. DOI: 10.1158/0008-5472.CAN-05-0137. View

12.

Calin G, Croce C . MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6(11):857-66. DOI: 10.1038/nrc1997. View

13.

Wang X, Wang W, Zhang Z, Zhao J, Tan X, Luo J . Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat Oncol. 2013; 8:146. PMC: 3698151. DOI: 10.1186/1748-717X-8-146. View

14.

Schramedei K, Morbt N, Pfeifer G, Lauter J, Rosolowski M, Tomm J . MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene. 2011; 30(26):2975-85. PMC: 3134876. DOI: 10.1038/onc.2011.15. View

15.

Cohen H, McGovern F . Renal-cell carcinoma. N Engl J Med. 2005; 353(23):2477-90. DOI: 10.1056/NEJMra043172. View

16.

Dong G, Liang X, Wang D, Gao H, Wang L, Wang L . High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation. Med Oncol. 2014; 31(7):57. DOI: 10.1007/s12032-014-0057-x. View

17.

Hatley M, Patrick D, Garcia M, Richardson J, Bassel-Duby R, Van Rooij E . Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010; 18(3):282-93. PMC: 2971666. DOI: 10.1016/j.ccr.2010.08.013. View

18.

Najafi Z, Sharifi M, Javadi G . Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma. Cancer Gene Ther. 2015; 22(11):530-5. DOI: 10.1038/cgt.2015.51. View

19.

Wang Z, Han J, Cui Y, Zhou X, Fan K . miRNA-21 inhibition enhances RANTES and IP-10 release in MCF-7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration. Biochem Biophys Res Commun. 2013; 439(3):384-9. DOI: 10.1016/j.bbrc.2013.08.072. View

20.

Bukowski R . Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer. 2009; 115(10 Suppl):2273-81. DOI: 10.1002/cncr.24226. View